机构:[1]Institute of Biomedical Engineering, Kunming Medical University, Kunming, China.[2]Kunming Medical University, Kunming, China.[3]Department of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China.昆明医科大学附属第一医院外科科室神经外科神经外一科(神经外科)[4]Clinical Medical Research Center for Obstetrics and Gynecology (Yunnan Joint Key Laboratory), Kunming City of Maternal and Child Health Hospital, Kunming City of Women and Children, Kunming, China.
The author(s) declare financial support was received for the
research, authorship, and/or publication of this article. This work is
supported by the National Natural Science Foundation of China
(81760273 and 81360103); the Digital Development and Application
第一作者机构:[1]Institute of Biomedical Engineering, Kunming Medical University, Kunming, China.[2]Kunming Medical University, Kunming, China.
通讯作者:
通讯机构:[2]Kunming Medical University, Kunming, China.[3]Department of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China.[4]Clinical Medical Research Center for Obstetrics and Gynecology (Yunnan Joint Key Laboratory), Kunming City of Maternal and Child Health Hospital, Kunming City of Women and Children, Kunming, China.
推荐引用方式(GB/T 7714):
Ma Yantuanjin,Deng Xingli,Shen Ru,et al.Unveiling immune tolerance pathways in preeclampsia placenta: implications for molecular targets and discovery of potential biomarkers[J].Frontiers In Endocrinology.2024,15:1385154.doi:10.3389/fendo.2024.1385154.
APA:
Ma Yantuanjin,Deng Xingli,Shen Ru,Zhang Hongqing&Qian Yuan.(2024).Unveiling immune tolerance pathways in preeclampsia placenta: implications for molecular targets and discovery of potential biomarkers.Frontiers In Endocrinology,15,
MLA:
Ma Yantuanjin,et al."Unveiling immune tolerance pathways in preeclampsia placenta: implications for molecular targets and discovery of potential biomarkers".Frontiers In Endocrinology 15.(2024):1385154